Publications by authors named "Shizuo Machida"

Claim this Profile
E
Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabine.
Yoshifumi Takahashi, Yuji Takei, Shizuo Machida, Akiyo Taneichi, Suzuyo Takahashi

J Obstet Gynaecol Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New criteria for the omission of lymphadenectomy in endometrioid carcinoma.
Chikako Matsushita, Hiroyuki Fujiwara, Yuji Takei, Yasushi Saga, Shizuo Machida

Int J Gynecol Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion?
Shizuo Machida, Shigeki Matsubara, Hiroyuki Fujiwara, Yuji Takei

J Oncol Pharm Pract· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
Yuji Takei, Suzuyo Takahashi, Shizuo Machida, Akiyo Taneichi, Takahiro Yoshiba

Int J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimens.
Yuji Takei, Yoshifumi Takahashi, Shizuo Machida, Akiyo Taneichi, Suzuyo Takahashi

J Obstet Gynaecol Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of endometrial cancer patients with and without symptoms at recurrence.
Takahiro Yoshiba, Yuji Takei, Shizuo Machida, Akiyo Taneichi, Naoto Sato

J Obstet Gynaecol Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immature ovarian teratoma with hyponatremia and low serum vasopressin level.
Yuki Sakamoto, Yuji Takei, Yasushi Saga, Shizuo Machida, Yoshifumi Takahashi

J Obstet Gynaecol Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian nongestational choriocarcinoma and associated adenocarcinoma with the same germ cell origin determined by a molecular genetic approach: A case report.
Takahiro Koyanagi, Hiroyuki Fujiwara, Hirokazu Usui, Haruko Ariga, Shizuo Machida

Pathol Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Yoshifumi Takahashi, Yasushi Saga, Takahiro Koyanagi, Yuji Takei, Shizuo Machida

Cancer Sci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gestational choriocarcinoma with uterine serosal metastasis mimicking ruptured ectopic pregnancy: A case report.
Yuki Sakamoto, Yuji Takei, Hiroyuki Fujiwara, Shizuo Machida, Akiyo Taneichi

Oncol Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of providing risk information on undergoing cervical cancer screening: a randomized controlled trial.
Hiroyuki Fujiwara, Akihiro Shimoda, Yoshiki Ishikawa, Akiyo Taneichi, Mai Ohashi, Shizuo Machida

Arch Public Health· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
Akiyo Taneichi, Hiroyuki Fujiwara, Yoshifumi Takahashi, Yuji Takei, Shizuo Machida

Int J Gynecol Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-based interventions to improve HPV vaccination coverage among 13- to 15-year-old females: measures implemented by local governments in Japan.
Hiroyuki Fujiwara, Yuji Takei, Yoshiki Ishikawa, Yasushi Saga, Shizuo Machida

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer.
Shizuo Machida, Yuji Takei, Chikako Yoshida, Yoshifumi Takahashi, Takahiro Koyanagi

Oncology· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated intravascular coagulopathy caused by uterine leiomyoma with sarcoma-like findings on magnetic resonance imaging.
Akiyo Taneichi, Hiroyuki Fujiwara, Yukako Mizoguchi, Shizuo Machida, Hiroaki Nonaka

Case Rep Obstet Gynecol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer.
Takahiro Koyanagi, Yasuhiro Suzuki, Yasushi Saga, Shizuo Machida, Yuji Takei

Cancer Sci· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3.
Kayoko Takahashi, Hiroaki Mizukami, Yasushi Saga, Yuji Takei, Masashi Urabe, Shizuo Machida

Cancer Sci· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation.
Naoto Sato, Yasushi Saga, Hiroaki Mizukami, Dongdong Wang, Suzuyo Takahashi, Shizuo Machida

Oncol Rep· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma.
Shizuo Machida, Tomomi Sato, Hiroyuki Fujiwara, Yasushi Saga, Yuji Takei

Oncol Lett· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies.
Muneaki Shimada, Hiroyuki Fujiwara, Shinya Sato, Tetsuro Oishi, Hiroaki Itamochi, Shizuo Machida

Cancer Chemother Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations.
Naoto Sato, Yasushi Saga, Hiroaki Mizukami, Dongdong Wang, Hiroyuki Fujiwara, Shizuo Machida

Oncol Rep· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma.
Hiroyuki Fujiwara, Toshiko Jobo, Yuji Takei, Yasushi Saga, Manami Imai, Shizuo Machida

Oncol Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy.
Dongdong Wang, Yasushi Saga, Hiroaki Mizukami, Naoto Sato, Hiroaki Nonaka, Shizuo Machida

Int J Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a formula for individual dosage of nedaplatin based on renal function.
Shinya Sato, Hiroyuki Fujiwara, Tetsuro Oishi, Muneaki Shimada, Shizuo Machida

Cancer Chemother Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion.
Hiroaki Nonaka, Yasushi Saga, Hiroyuki Fujiwara, Hidetoshi Akimoto, Akiyo Yamada, Shizuo Machida

Int J Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis